Work

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

Year: 2002

Type: article

Source: Blood

DOI: 10.1182/blood.v99.10.3792

Authors: Melissa S. Holtz, Marilyn L. Slovak, Feiyu Zhang, Charles L. Sawyers, Stephen J. Forman, Ravi Bhatia

Institutions: City Of Hope National Medical Center, University of California, Los Angeles

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Cancer Center Support Grant, RESTORATION OF INTEGRIN FUNCTION IN CML BY INTERFERON

OpenAlex ID: W1968655578

FWCI: 10.22

Cites: 47

Cited by: 251

Related to: 10